BeOne Medicines (ONC) FCF Margin (2015 - 2026)
BeOne Medicines (ONC) posted quarterly FCF Margin of 10.45% for Q1 2026, up 1187.0% year-over-year from 0.81% in Q1 2025, and down 69.22% quarter-over-quarter from 33.93% in Q4 2025.
BeOne Medicines (ONC) FCF Margin (2015 - 2026) Analysis & Trends
BeOne Medicines (ONC) has reported FCF Margin for 12 consecutive years, with 10.45% the latest figure, recorded in Q1 2026.
- In Q1 2026, FCF Margin rose 1187.0% year-over-year to 10.45%; the TTM figure through Mar 2026 stood at 21.68% (up 1597.0% YoY), while the FY2025 annual figure was 20.03%, up 2557.0% from the prior year.
- FCF Margin eased to 10.45% in Q1 2026 per ONC's latest filing, from 33.93% in the prior quarter.
- Across five years, FCF Margin topped out at 33.93% in Q4 2025 and bottomed at 182.47% in Q3 2022.
- Historically, FCF Margin has averaged 41.35% across 5 years, with a median of 5.87% in 2024.
- On a YoY basis, FCF Margin climbed as much as 19833 bps in 2022 and fell as far as 16976 bps in 2022.
- BeOne Medicines' FCF Margin stood at 115.64% in 2022, then soared by 72 bps to 32.44% in 2023, then surged by 122 bps to 7.11% in 2024, then jumped by 377 bps to 33.93% in 2025, then plunged by 69 bps to 10.45% in 2026.
- Business Quant data shows ONC's FCF Margin at 10.45% in Q1 2026, 33.93% in Q4 2025, and 25.1% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -18,629.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.68% |
| Mar 31, 2026 | 10.45% |
| Dec 31, 2025 | 33.93% |
| Sep 30, 2025 | 25.10% |
| Jun 30, 2025 | 16.98% |
| Mar 31, 2025 | -1.43% |
| Dec 31, 2024 | 7.11% |
| Sep 30, 2024 | 22.83% |
| Jun 30, 2024 | -5.87% |
| Mar 31, 2024 | -61.88% |
| Dec 31, 2023 | -32.44% |
| Sep 30, 2023 | 7.85% |
| Jun 30, 2023 | -80.12% |
| Mar 31, 2023 | -140.19% |
| Dec 31, 2022 | -115.64% |
| Sep 30, 2022 | -182.47% |
| Jun 30, 2022 | -115.20% |
| Mar 31, 2022 | -91.87% |
| Dec 31, 2021 | 54.11% |
| Sep 30, 2021 | -221.22% |